Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-CellsDevelopment and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells
|
| 0 Comment
Adoptive most cancers immunotherapy utilizing chimeric antigen receptor (CAR) engineered T-cells holds nice promise, though a number of obstacles hinder the environment friendly technology of cell merchandise beneath good manufacturing